Variable | Total (n = 115) |
---|---|
Age : mean ± SD | 65.1 ± 11.0 |
Sex: Male/female | 93/22 |
Primary site | Â |
Oropharyngeal | 25(21.7%) |
Hypopharyngeal | 25(21.7%) |
Laryngeal | 23(20%) |
Oral cavity | 31(27%) |
Nasal cavity | 11(9.6%) |
Tumor grade: | 45(39.1%)/48(41.7%)/22(19.1%) |
well/ moderate/poor | |
T stage: T1/T2/T3/T4 | 16/45/27/27 |
(13.9%/39.1%/23.5%/23.5%) | |
N stage: N0/N1/N2/N3 | 59/17/39/0 |
(51.3%/14.8%/33.9%/0%) | |
Stage: I/II/III/IV | 12/23/26/54 |
(10.4%/20%/22.6%/47.0%) |